Related Experiment Video
Updated: Jun 12, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Excessive sleepiness.
1Department of Internal Medicine, Division of Sleep Medicine, National Jewish Health, University of Colorado, Denver School of Medicine, 1400 Jackson Street, Denver, CO 80206, USA. tsais@njhealth.org
Excessive sleepiness affects many people, increasing risks for mood disorders, cardiovascular issues, and public safety incidents like accidents. This review covers sleepiness evaluation, causes, and management strategies.
Area of Science:
- Neurology
- Public Health
- Sleep Medicine
Background:
- Chronic sleepiness affects up to 20% of the population.
- Sleepiness is linked to mood disorders and cardiovascular risks.
- It poses significant public health risks, including accidents and medical errors.
Purpose of the Study:
- To review the public health implications of sleepiness.
- To discuss methods for evaluating sleepiness.
- To outline disorders causing sleepiness and their management.
Main Methods:
- Literature review of sleepiness research.
- Analysis of public health data related to sleepiness.
- Synthesis of clinical guidelines for sleep disorder management.
Main Results:
- Sleepiness has broad systemic health impacts.
- It is a major contributor to accidents and errors.
- Effective management strategies exist for sleep disorders.
Conclusions:
- Addressing sleepiness is crucial for individual and public health.
- Comprehensive evaluation and management are key.
- Further research can improve patient outcomes and safety.
Related Concept Videos
Narcolepsy
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleep Apnea
The condition is more prevalent among...

